USPTO serial 98116944
RADDISH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 12, 2026
- Examiner
- CHONG, JESSICA EUNKYO
- Law office
- TMEG LAW OFFICE 105
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with RADDISH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Global Alzheimer's Platform Foundation Inc.
Washington, DC, US
Other trademarks owned by Global Alzheimer's Platform Foundation Inc.
Global Alzheimer's Platform Foundation Inc.
Washington, DC, US
Other trademarks owned by Global Alzheimer's Platform Foundation Inc.
Global Alzheimer's Platform Foundation Inc.
Washington, DC, US
Other trademarks owned by Global Alzheimer's Platform Foundation Inc.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christopher A. Proskey
Christopher A. Proskey BROWNWINICK LAW FIRM666 GRAND AVE., SUITE 2000DES MOINES, IA 50309United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Promoting public awareness of Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases and issues related thereto in the nature of patient registries, patient research, patient advocacy and patient fundraising efforts; Promoting public awareness of health care issues for patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases, and the importance of patient registration on Alzheimer's, neurodegenerative diseases and other neurological and central nervous system disease registries; Charitable services, namely, organizing and developing programs that aim to improve the lives of patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system disease patients, their caregivers and families; Charitable business services, namely, administration of programs for enabling participants to receive services for Alzheimer's, neurodegenerative diseases and other neurological and central nervous system disease patients, their caregivers and families; Business services, namely, recruitment of participants for neuroscience clinical research; Maintaining a registry of participants for neuroscience clinical research relating to the treatment and prevention of brain disease; Promoting participation in clinical trials and research in the neuroscience field; Recruitment advertising services, namely, advertising clinical trials for the purpose of recruiting patients and placing patients for participation in clinical trials in the neuroscience field | ACTIVE | Jun 30, 2025 |
| 036 | Charitable fundraising; Charitable fundraising for Alzheimer's disease and neurodegenerative disease research and treatment | ACTIVE | Jun 30, 2025 |
| 042 | Scientific research in the nature of conducting clinical trials and research for others in the field of Alzheimer's, neuro degenerative diseases and other neurological and central nervous system diseases; Medical and scientific research, namely, conducting clinical trials for others; Medical and scientific research, namely, conducting clinical trials for patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases | ACTIVE | Jun 30, 2025 |
| 044 | Healthcare services; Healthcare services, namely, administering care to patients; Healthcare services, namely, administering care to patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Healthcare services, namely, administering tests for patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Healthcare services, namely, taking samples from patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Establishing tissue, bloods, organ, and stem cell bank of biological samples related to Alzheimer's neurodegenerative diseases and other neurological and central nervous system diseases; Providing health screening services in the field of Alzheimer's, neurodegenerative diseases, and other neurological and central nervous system diseases; Providing health screening services related to Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases | ACTIVE | Jun 30, 2025 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Global Alzheimer's Platform Foundation Inc.
- Other trademarks owned by Global Alzheimer's Platform Foundation Inc.
- Other trademarks owned by Global Alzheimer's Platform Foundation Inc.
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named RADDISH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 12, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 12, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 17, 2026 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Apr 17, 2026 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Apr 1, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 14, 2025 | IUAF | USE AMENDMENT FILED | — |
| Oct 14, 2025 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Apr 12, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 12, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 11, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 11, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 15, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 20, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 20, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 31, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 17, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 16, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 16, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 16, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 16, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 8, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 8, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 8, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 8, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 8, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 8, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 5, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 3, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 8, 2023 | NWAP | NEW APPLICATION ENTERED | — |